Announcements
April 7, 2021

Regenstrief Institute names chief financial officer

Deborah Strombaugh
Deborah Lynn Stombaugh will join Regenstrief Institute as chief financial officer (CFO) on April 16, 2021.

In her new role, she will advise the president and board of directors of the institute on all matters pertaining to financial policy, manage the day-to-day administration and control of accounting, financial reporting and payroll functions as well as overseeing grants and contracts management.

“We look forward to Deb Stombaugh assuming her new responsibilities as Regenstrief Institute’s CFO and working with the leadership team to develop strategies for the institute’s financial future, maximizing resources and minimizing obstacles to success,” said Peter Embí, M.D., president and CEO. “She has a proven track record as a forecaster, planner, innovator and problem solver.”

Stombaugh previously held the positions of associate chief operating officer of Indiana University School of Medicine and, most recently, vice chair for clinical and academic administration in IU School of Medicine’s Department of Medicine. Additionally, she served on the IU School of Medicine Taskforce on Space, Assessments, and Long-Term Investments, the Eskenazi Medical Group External Compensation Committee, the IU Health Physicians Finance Committee and the IU Health Physicians Enterprise Alignment Transition Coordination Team.

Stombaugh holds a bachelor’s degree from North Park University in Chicago and a master of science in management from the Krannert Graduate School of Management at Purdue University.

About Regenstrief Institute

Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists and fellows shared work on artificial intelligence, health information exchange and public health informatics at

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight